Avacta Group plc has announced the appointment of David Bryant and Richard Hughes as Non-Executive Directors, effective immediately. David Bryant brings over 35 years of experience in the pharmaceutical industry, with previous roles at GSK, Pfizer, and Clinigen Group. Richard Hughes has over 30 years of experience in UK capital markets, having been involved in corporate finance, IPOs, and M&A. The appointments are expected to enhance the Board's capabilities as the company focuses on advancing its preCISION® platform.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avacta Group plc published the original content used to generate this news brief on May 28, 2025, and is solely responsible for the information contained therein.